Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 63 | ECE2019 | Next issue

21st European Congress of Endocrinology

Lyon, France
18 May 2019 - 21 May 2019

Card image cap
18-21 May 2019, Lyon, France

Poster Presentations

Adrenal and Neuroendocrine Tumours 2

Previous section
Thyroid 1
Table of contents
Next section
Calcium and Bone 2

ea0063p407 | Adrenal and Neuroendocrine Tumours 2

ACTH-dependent hypercortisolism: always follow your nose

ea0063p408 | Adrenal and Neuroendocrine Tumours 2

Metyrapone test in secondary adrenal insufficiency – is ACTH measurement alone sufficient for a proper diagnosis?

ea0063p409 | Adrenal and Neuroendocrine Tumours 2

Diagnostic accuracy of the aldosterone to active renin ratio in detecting primary aldosteronism: the graz endocrine causes of hypertension (GECOH) study

ea0063p410 | Adrenal and Neuroendocrine Tumours 2

Large adrenal incidentalomas require a dedicated diagnostic procedure

ea0063p411 | Adrenal and Neuroendocrine Tumours 2

Necessity of educational programs for healthcare givers in preclinical settings of acute adrenal insufficiency in patients with chronic hypocortisolism

ea0063p412 | Adrenal and Neuroendocrine Tumours 2

Challenges in diagnosing and treating a glucagon secreting tumor – case report

ea0063p413 | Adrenal and Neuroendocrine Tumours 2

Phenotypic variability within a family with multiple endocrine neoplasia type 1 (MEN1) syndrome

ea0063p414 | Adrenal and Neuroendocrine Tumours 2

High levels of chromogranin A in connection with proton pump inhibitors

ea0063p415 | Adrenal and Neuroendocrine Tumours 2

A case of pheochromocytoma left untreated for twelve years: Role of the endocrinologist

ea0063p416 | Adrenal and Neuroendocrine Tumours 2

High prevalence of autonomous aldosterone secretion in patients with type 2 Diabetes Mellitus and arterial hypertension. The effect of SGLT2 inhibitors on renin-angiotensin-aldosterone system

ea0063p417 | Adrenal and Neuroendocrine Tumours 2

Extreme improvement in metabolic status with remarkable weight loss of 64 kg after adrenalectomy due to Cushing syndrome, and development of rheumatoid arthritis eight months later

ea0063p418 | Adrenal and Neuroendocrine Tumours 2

Contribution of morphological and functional liver imaging to differentiate liver metastases of adrenocortical carcinoma from those of neuroendocrine tumors in a woman with a final diagnosis of multiple endocrine neoplasia type 1

ea0063p419 | Adrenal and Neuroendocrine Tumours 2

Prolonged hypoaldosteronism after unilateral adrenalectomy for primary aldosteronism: a report of two cases

ea0063p420 | Adrenal and Neuroendocrine Tumours 2

Premature ovarian failure in a patient with schmidt syndrome

ea0063p421 | Adrenal and Neuroendocrine Tumours 2

RET Y791F carriers’ medical history – experience from one center

ea0063p422 | Adrenal and Neuroendocrine Tumours 2

Association between new anthropometric parameters and new inflammation indicators in non-functioning adrenal incidentalomas

ea0063p423 | Adrenal and Neuroendocrine Tumours 2

Comparison of visualization methods in ACTH-ectopic lung tumor: a case report

ea0063p424 | Adrenal and Neuroendocrine Tumours 2

Paraneoplastic Cushing’s syndrome related to recurrence of a malignant ovarian teratoma

ea0063p425 | Adrenal and Neuroendocrine Tumours 2

Insulinoma: a case series of a tertiary care center

ea0063p426 | Adrenal and Neuroendocrine Tumours 2

Validation of 24-hour human adrenal steroid rhythms measured by ULTRADIAN interstitial automated microdialysis: Comparison with plasma

ea0063p427 | Adrenal and Neuroendocrine Tumours 2

Genetic mutations in bladder paragangliomas - not just SDHB-related disease

ea0063p428 | Adrenal and Neuroendocrine Tumours 2

PAI-BEL: the Belgian registry on Primary Adrenal Insufficiency

ea0063p429 | Adrenal and Neuroendocrine Tumours 2

Urinary steroid profiling by gas chromatography-mass spectrometry (GC-MS) in Cushing’s syndrome

ea0063p430 | Adrenal and Neuroendocrine Tumours 2

Efficacy of DHEA in improving Quality of Life in prolonged HPA axis suppression from exogenous steroids

ea0063p431 | Adrenal and Neuroendocrine Tumours 2

Residual adrenocortical function in autoimmune addison’s disease: interim results of a cross-sectional study

ea0063p432 | Adrenal and Neuroendocrine Tumours 2

Case report: giant adrenal myelolipoma in CAH – should all patients be screened by ultrasound for adrenal masses?

ea0063p433 | Adrenal and Neuroendocrine Tumours 2

Molecular events in a large series of advanced stage III-IV adrenocortical cancer: looking for new therapeutic options

ea0063p434 | Adrenal and Neuroendocrine Tumours 2

A severe ACTH-dependent Cushing syndrome associated to a possible concomitant primary adrenal-dependent hypercortisolism: a challenging case

ea0063p435 | Adrenal and Neuroendocrine Tumours 2

One-hour glucose level of the oral glucose tolerance test: the new valuable indicator of insulin resistance in patients with adrenal incidentalomas

ea0063p436 | Adrenal and Neuroendocrine Tumours 2

Measuring steroids hormones by liquid chromatography–tandem mass spectrometry in 21-hydroxylase deficiency (21OHD) reveal large interindividual differences in hormone levels amongst patient with the same genetic mutation

ea0063p437 | Adrenal and Neuroendocrine Tumours 2

Hypoadrenalism in Advanced HIV

ea0063p438 | Adrenal and Neuroendocrine Tumours 2

A case of late recognition of the malignant cause of chronic pancreatitis

ea0063p439 | Adrenal and Neuroendocrine Tumours 2

Imaging studies of a parathyroid carcinoma case

ea0063p440 | Adrenal and Neuroendocrine Tumours 2

Neuroendocrine neoplasms (NEN) arising in uncommon sites: epidemiological and clinical features

ea0063p441 | Adrenal and Neuroendocrine Tumours 2

Microwave ablation of the adrenal gland for treatment of functioning adrenocortical tumours: porcine in vivo study

ea0063p442 | Adrenal and Neuroendocrine Tumours 2

Simplified model for diagnosis of secondary adrenal insufficiency using non-fasting cortisol and clinical parameters

ea0063p443 | Adrenal and Neuroendocrine Tumours 2

Type 1 gastric neuroendocrine tumor study in Hospital Clínico San Carlos (HCSC), Madrid

ea0063p444 | Adrenal and Neuroendocrine Tumours 2

The Arg244His missense mutation in SDHB-1 leads to altered metabolism in Caenorhabditis elegans: a new disease model

ea0063p445 | Adrenal and Neuroendocrine Tumours 2

11C-Metomidate PET/CT Identifies Unilateral Primary Aldosteronism in a Multi-ethnic Cohort

ea0063p446 | Adrenal and Neuroendocrine Tumours 2

Prevalence of non-carcinoid syndrome (non-CS) diarrhoea in patients with neuroendocrine tumours (NETs): a systematic literature review (SLR)

ea0063p447 | Adrenal and Neuroendocrine Tumours 2

Down-regulation of the Ataxia Telangiectasia Mutated Gene (ATM) is associated with increased metastatic potential and decreased overal survival in patients diagnosed with gastroenteropancreatic neuroendocrine tumors (GEP-NETs)

ea0063p448 | Adrenal and Neuroendocrine Tumours 2

GEP-NET tumors as the first geno-phenotypic association in MEN1 syndrome – the possibilities for a European MEN1 network

ea0063p449 | Adrenal and Neuroendocrine Tumours 2

Prevalence of neuroendocrine tumors in a subgroup of young patients: single center experience

ea0063p450 | Adrenal and Neuroendocrine Tumours 2

Prognostic role of angiogenesis-associated factors Tie2 and Angiopoietin 2 in patients with neuroendocrine neoplasms: The NETTARE Unit experience

ea0063p451 | Adrenal and Neuroendocrine Tumours 2

Attributes valued by patients, health-care practitioners (HCPs) and caregivers using pre-filled delivery systems: a systematic literature review

ea0063p452 | Adrenal and Neuroendocrine Tumours 2

Identification of a molecular signature of hypercortisolism by whole blood methylome analysis

ea0063p453 | Adrenal and Neuroendocrine Tumours 2

Risk factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a case-control study from NETTARE Unit

ea0063p454 | Adrenal and Neuroendocrine Tumours 2

Selective arterial calcium stimulation test in two cases with occult insulinoma

ea0063p455 | Adrenal and Neuroendocrine Tumours 2

Can pancreatic tumor in von Hippel-Lindau syndrome be a prognostic factor?– a case study

ea0063p456 | Adrenal and Neuroendocrine Tumours 2

An investigation into the role of parathyroid hormone in the regulation of aldosterone secretion in hypertensive cardiovascular patients

ea0063p457 | Adrenal and Neuroendocrine Tumours 2

Plasma levels and regulation by the hypothalamic–pituitary–adrenal axis of Androst-5-ene-3β,7α/β,17β-triols in human

ea0063p458 | Adrenal and Neuroendocrine Tumours 2

A case of non metastatic pheochromocytoma in a patient with multiple sclerosis

ea0063p459 | Adrenal and Neuroendocrine Tumours 2

Bilateral gynecomastia revealing a secreting adrenal adrenoma on a 5-year-old boy

ea0063p460 | Adrenal and Neuroendocrine Tumours 2

Steroid hormones and cancer immunity - insights into adrenocortical carcinoma

ea0063p461 | Adrenal and Neuroendocrine Tumours 2

Multiple endocrine neoplasia: A case report of a pancreatic neuroendocrine tumor in a long evolving MEN1 patient

ea0063p462 | Adrenal and Neuroendocrine Tumours 2

A clinical case of adrenal incidentaloma: inconsistency of a prediction to reality

ea0063p463 | Adrenal and Neuroendocrine Tumours 2

InfeCtious disease in patients with Adrenal endocRinOpathies: the ICARO prospective observational study

ea0063p464 | Adrenal and Neuroendocrine Tumours 2

EGFR and IGF1R affect Sunitinib activity: novel targets for Broncho-Pulmonary Neuroendocrine Neoplasm treatment

ea0063p465 | Adrenal and Neuroendocrine Tumours 2

Measurement of metanephrine in adrenal venous sampling may help subtyping primary aldosteronism

ea0063p466 | Adrenal and Neuroendocrine Tumours 2

A case of metastatic pheochromocytoma diagnosed at a young age with hypertensive attack

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more